May 28, 2025

Inexpensive Pill Improves Vision in DME Patients

"A $20 a month or even cheaper oral pill ... could be life changing for patients in regions with limited access to specialty doctors."

Reuters

May 15, 2025

Visual Difficulty, Falls, and Mortality

Recurrent falls were associated with a nearly 50% increased hazard of mortality.

Conexiant

April 24, 2025

FDA Rejects Extended Dosing Intervals for Eylea HD

The agency did not agree with Regeneron’s proposal to add dosing intervals greater than every 16 weeks, the maximum interval currently indicated for aflibercept 8 mg injections.

Retinal Physician

February 26, 2025

Integration of Vision Services Remains an Unmet Need in FQHCs

Telemedicine, funding, and provider partnerships can help, researchers say.

Conexiant

April 09, 2025

Port Delivery System With Ranibizumab for Diabetic Eye Disease

Researchers determined that the PDS may decrease the treatment burden of frequent intravitreal injections, but further research on efficacy and safety is needed.

Conexiant

April 02, 2025

GLP-1 RAs Evaluated for Long-Term Risk of NAION in Patients With Diabetes

Researchers’ subgroup analyses provide data on increased risks according to timepoint, demographics, and comorbidities.

Conexiant

November 08, 2024

Is Intravenous Methylprednisolone Efficacious for Visual Complications of GCA?

While timely treatment is essential to protect vision, the researchers found no visual acuity benefit with IVMP.

Conexiant

December 03, 2024

Novel Eye Perfusion Model Advances Retinal Disease Research

Innovative perfusion techniques recreate physiological conditions in the retina, offering a powerful tool for studying blindness and eye diseases.

Conexiant

December 16, 2024

Does Ozempic Double Eye Disease Risk?

Danish health authorities seek EU review of studies linking Novo Nordisk's Ozempic to rare eye condition in type 2 diabetes patients.

Reuters